Imaging3 and Greenberg Glusker Reach Agreement on Legal Fees
Scott R. Pancoast Joins the Imaging3 Team
Imaging3, Inc. (OTCQB: “IGNG”) Announces Execution of Consulting Service Agreement with Biologics Consulting Group, Inc.
Imaging3, Inc. (OTCQB: “IGNG”) Announces execution of agreement with CriTech Research to Complete Software Verification, Validation and Remediation for the Company’s Planned FDA 510(k) Application
Imaging3, Inc. Announces Commencement of Trading of its Common Stock on the OTCQB under Trading Symbol “IGNG”.
Imaging3, Inc. announces it is now approved for trading.
Imaging3, Inc. Announces 2012-2013, 2103-2014, 10K’s completed.
Imaging3, Inc. Announces 2015 Outlook and Updates
Imaging3 Announces New Board of Directors Members